Advert - Pharmasure – AUTH/3407/10/20
Promotion of Meriofert/breach of undertaking
-
Date posted02 August 2021
-
SanctionAdvertisement,
-
Case number/s
For failing to comply with a previous undertaking and continuing to use claims for Meriofert (menotrophin) which had previously been ruled to be in breach of the Code, Pharmasure acknowledged the further following breaches of the Code:
Clause 2 - Bringing discredit upon, and reducing confidence in, the pharmaceutical industry
Clause 29 - Failing to comply with an undertaking